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Abstract 
Background: First and second-degree heart blocks are partly common rhythm disorders in thalassemic 
patients but complete heart block is a very rare complication of iron overload cardiomyopathy.  
Case Presentation: This 15-year-old boy, a known case of major β-thalassemia was admitted to our 
emergency unit with dyspnea and cough because of decompensated heart failure. The electrocardiogram 
showed complete heart block with junctional escape rhythm. Interestingly, his previous electrocardiogram 
taken 2 months earlier, had some PVC and second degree, Mobitz type 1 (Wenckebach) heart block. After 
improvement of dyspnea and control of blood pressure in normal range, the patient was referred to ER. A 
dual-chamber permanent pacemaker was implanted and his symptoms improved, but he died 24 days after 
discharge from hospital. 
Conclusion: We present a rare case of complete heart block after a second-degree (Mobitz 1) heart block that 
was due to severe iron overload cardiomyopathy. 
Iranian Journal of Pediatrics, Volume 22 (Number 2), June 2012, Pages: 260-264 
Key Words: β-Thalassemia, Arrhythmia, Iron overload; Cardiomyopathy
Introduction 
Thalassemia major is the most common 
monogenic disorder causing a complete absence of 
β-globin gene production [1]. There is some 
inevitably pursuant complication in thalassemia 
major patient from iron overload in various 
organs such as heart, liver and pancreas. Cardiac 
iron overload or iron overload cardiomyopathy 
(IOC) is the most serious condition [2]. Congestive 
heart failure and cardiac arrhythmias are the most 
common lethal complications in these patients. 
First and second-degree heart blocks are partly 
common rhythm disorders in thalassemic patients 
but complete heart block is an absolutely rare 
complication [3]. We present here the case of a 
young boy with second and third degree heart 
block and severe congestive heart failure due to 
IOC. 
Case Presentation 
This 15-year-old boy was admitted to our 
emergency unit with complaints of abdominal and 
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back pain, dyspnea and cough for 2-3 months 
prior to presentation. He was a known case of 
major β-thalassemia who had been hospitalized 
twice for the same complaints during the last two 
months. The diagnosis was made by the age of 8 
months [hemoglobin (Hgb) A 87.5%, Hgb A2 2.2%, 
Hgb F 10.3%] and from then on, he underwent 
intermittent whole blood transfusions every 25 
days (390 milliliter at last time). Subcutaneous 
deferoxamine injection started at age 5, using 
portable pump. He has had good compliance for 
blood transfusion and chelation therapy.  
     His past medical history included splenectomy 
at age 6. Physical examination revealed a lethargic 
and febrile boy with a typical thalassemic feature, 
mild jaundice and respiratory distress at rest. His 
pulse rate was 42/min with blood pressure 
108/72 mmHg and 93% arterial O2 saturation 
(with pulse-oximetery). He had periorbital and 
lower limb edema, pale conjunctivae and icteric 
sclera. Examination of cardiovascular system 
revealed muffled cardiac sounds with no 
detectable murmur. His right jugular vein 
pulsation point was raised and prominent. Lung 
auscultation was clean but there was decreased 
breathing sound in both lungs that was more 
severe in the bases of the lungs. Examination of 
the abdomen revealed a huge tender 
hepatomegaly, distension and dullness in 
percussion.  A 15 cm midline scar was also seen in 
abdomen. Laboratory findings: hemoglobin 11,4 
mg/dl, mean cell volume 98.32 fL, white cells 
11.6×109/L, platelets 161×106/L, potassium 5 
mg/dl, urea 13 mg/dl, creatinine 0.6 mg/dl, blood 
glucose 74 mg/dl, serum iron 219 μg/dl, ferritin 
7600 ng/ml, total iron binding capacity (TIBC) 
250mg/dl, serum glutamic oxaloacetic trans-
aminase (SGOT) 84 IU/L, serum glutamic pyruvic 
transaminase (SGPT) 54 IU/L, C-reactive protein 
(qualitative) negative and calcium 8.6 mg/dl. 
Blood culture was negative for bacterial aerobic 
and anaerobic growth.  
     Chest x-ray showed increased cardio-thoracic 
ratio and some areas of consolidation in both 
lungs (Fig. 1). Also bilateral pleural effusion was 
detected by chest ultrasonography. A trans-
thoracic echocardiogram revealed mild mitral 
regurgitation and moderate tricuspid regur-
gitation and a diffused dilation of all cardiac 
chambers. Right and left ventricle had severe 
systolic dysfunction. Also massive pericardial 
effusion was detected. Unfortunately, cardiac MRI 
was not performed.  
     The electrocardiogram showed complete heart 
block with junctional escape rhythm (Fig. 2). 
Interestingly, his previous electrocardiogram 
taken 2 months earlier had some premature 
ventricular contractions (PVC) and second degree 
 
Fig. 1: Patient’s chest x-ray on admission showed increased cardio-thoracic 
ratio and some areas of consolidation in both lungs 
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Fig. 2:  Electrocardiogram of patient at the last admission before pacemaker installation revealed 
complete atrioventricular block (third degree) with atrioventricular dissociation in long lead II (A), 
limb leads (B) and precordial leads (C) 
Mobitz type 1 (Wenckebach) heart block taken 2 
months earlier had some PVC and second degree 
Mobitz type 1 (Wenckebach) heart block (Fig. 3). 
     The patient was briefly managed with 
Furosemide, Captopril, Digoxin, Aldacton and 
Ceftriaxon. He had a fixed bradycardia (heart rate 
less than 45) that did not change after Dopamin 
infusion (15 drops per minute of 50% solution). 
After improvement of dyspnea and tachypnea and 
control of blood pressure in normal range, patient 
was referred for permanent pacemaker 
implantation. A dual-chamber permanent 
pacemaker (ST. JUDE MEDICAL) was implanted 
and his symptoms improved, but suddenly, he 
died 24 days later due to ventricular tachycardia. 
Discussion 
Cardiac complications of thalassemia major were 
first described by Engle and colleagues prior to 
introduction of chelation therapy[4]. Engle 
described the increase in heart size with first 
degree heart block after 10 years of age in one 
third of thalassemic patients. Generally, once heart 
failure occurs the survival time is less than three 
months if left untreated [5]. Currently, cardiomyo-
pathy is the leading cause of morbidity and 
mortality in 63.6% to 71% of patients [1]. Similar 
to mechanical dysfunction, electrophysiological 
dysfunction depends on the stage of disease [1]. 
Bradycardia, ST segment and T wave changes, 
infrequent premature atrial or ventricular 
contractions and first-degree atrioventricular 
block are the most common findings in early stage 
[6,9], that may progress to frequent premature 
atrial or ventricular contractions, short runs of 
supraventricular tachycardia and second-degree 
or third-degree heart block in the late stage[4,7]. 
Among these late electrocardiogram changes, 
frequent premature ventricular contraction is 
most commonly found [7]. Non-transferrin-bound 
iron (NTBI) has been shown to be the main cause 
of cytotoxicity[1]. Recently, the L-type calcium 
channel was proposed as the pathway of 
intracellular NTBI uptake in cardiomyocytes and 
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Fig 3: The 12 leads electrocardiogram from the previous admission of the patient revealed second 
degree Mobitz type 1(Wenkebach) heart block. 
calcium channel blockers have shown to be useful 
in preventing NTBI from entering cardiomyocytes 
via these channels [8]. 
     We could find only a case report of third-degree 
heart block in thalassemia major by 
Küçükosmanoğlu et al when searched PubMed and 
other electronic databases. Küçükosmanoğlu 
reported a case of complete heart block with 
serious congestive heart failure in whom 
management by pacemaker had no clinical 
improvement and the patient died in second 
month of hospitalization [3]. We presented here a 
thalassemia major patient with complete heart 
block. This arrhythmia was developed after a 
second-degree heart block and transient 
premature ventricular contractures from few 
months earlier. Similarly our patient died few 
weeks after pacemaker implantation. 
     These complications are reversible in some 
patients by early detection of iron deposition and 
then intensive iron chelation therapy [5]. The T2-
star magnetic resonance has been recently 
developed to assess cardiac iron status accurately 
and detect an early global ventricular dysfunction 
[9]. In comparison, conventional standard echo-
cardiography usually demonstrates positive 
findings at the late stage [10]. In our case MRI was 
not performed due to poor socioeconomic state of 
the family and late patient referral.  
     Patient's hemodynamic state was not stabilized 
using diuretics and digitalis because of low heart 
rate. So we administered cardiac dose of 
dopamine to increase cardiac output. Long term 
administration of third generation beta-blockers 
(e.g. Carvedilol) has been demonstrated to 
favorably affect survival in adult patients with 
severe chronic heart failure [11]. A recent study 
showed patients with thalassemia and dilated 
cardiomyopathy have poor tolerance to increasing 
Carvedilol dosage and develop decreased systolic 
blood pressure during advancement of the drug 
dosage [12]. Otherwise, many studies showed 
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reversibility of iron induced cardiomyopathy after 
treatment by chelation therapy in thalassemia 
major, but it is not universally accepted due to the 
high mortality of patients presenting with 
advanced cardiac failure despite chelation 
treatment [5]. 
Conclusion 
Atrioventricular blocks, especially complete heart 
block rarely occur in end-stage IOC. When these 
abnormalities developed, prognosis is very poor. 
Early detection of iron overload in asymptomatic 
patients is the goal of clinical management. 
Intensive iron chelation therapy is the best way of 
preventing iron overload. We present a rare case 
of complete heart block which developed after a 
second-degree (Mobitz 1) heart block due to 
severe IOC. 
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